Oniria Therapeutics raises $2 million to develop a drug designed to eliminate tumour cells that are resistant to conventional treatments

by BStartup

Founded in 2022 as a spin-off from Vall d'Hebron Institut d'Oncologia, the University of Barcelona and Icrea, Oniria Therapeutics specialises in the development of targeted therapies to eliminate pers...

Read more

Oniria Therapeutics closes €1.28 million seed funding round

by BStartup

The transaction was led by Mind the Gap, the Botin Foundation's biotechnology entrepreneurship programme, with participation from BStartup of Banco Sabadell, plus business angels and public funding (S...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

SICC Innvierte, a vehicle managed by CDT...

by CDTI Innovación

With a target size of €250 million, the fund aims to complete betwee...

Photos Stream